Brief: Autolus Therapeutics Reports First Quarter 2023 Financial Results And Operational Progress
04/05/2023 12:18
Autolus Therapeutics Plc AUTL.O :
* AUTOLUS THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND OPERATIONAL PROGRESS
* AUTOLUS THERAPEUTICS - ESTIMATES CURRENT CASH & CASH
EQUIVALENTS
ON HAND, ANTICIPATED FUTURE MILESTONE PAYMENT FROM BLACKSTONE TO
EXTEND RUNWAY INTO 2025
* QTRLY BASIC AND DILUTED NET LOSS PER ORDINARY SHARE $0.23
* Q1 EARNINGS PER SHARE VIEW $-0.27 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3L6Zns
Further company coverage: AUTL.O
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants